👀 Ones to watch: Undervalued stocks to buy before they report Q3 earningsSee Undervalued Stocks

Baird lifts Axon stock target, keeps outperform rating on growth potential

EditorNatashya Angelica
Published 09/10/2024, 09:54 PM
AXON
-


On Tuesday, Baird maintained its Outperform rating on shares of Axon Enterprise (NASDAQ:AXON), while increasing the stock's price target to $400 from the previous $360. The firm's analysts visited the company last week and expressed a continued bullish stance on the stock due to various growth opportunities anticipated in both the near and long term.


The analyst highlighted the potential for new artificial intelligence capabilities to act as a catalyst for Axon's growth in the upcoming quarters. Moreover, emerging opportunities in the enterprise sector and drone technology are expected to add long-term value. This optimism is built upon the solid growth from Axon's core products, including the Taser 10, Body Camera 4, and its software solutions.


Axon's software segment has shown impressive growth, with a 47% year-over-year increase in the second quarter, now approaching an annualized revenue of nearly $800 million. The firm's decision to raise the price target reflects confidence in the company's continued expansion and innovation in its product offerings.


The analyst's visit with Axon Enterprise provided insights into the company's strategic direction, reinforcing Baird's positive outlook. The firm's analysis suggests that Axon's diversified growth avenues, from its traditional products to new technological advancements, position the company favorably in the market.


The updated price target of $400 indicates Baird's expectation for Axon's stock performance, based on the company's strong growth metrics and potential market opportunities. Axon Enterprise's focus on integrating advanced technologies into its product suite appears to be a driving factor in the firm's valuation of the stock.


In other recent news, Axon Enterprise, Inc. reported a record-breaking second quarter, with revenue exceeding $500 million and new business bookings surpassing $1 billion.


The company's robust growth was driven by new products, TASER 10 and Axon Body 4, and a shift in revenue mix, with software and services accounting for 39% of total revenue. Axon also secured its largest records contract to date and saw its international bookings double.


The company's future contracted revenue stands at approximately $7.4 billion, and full-year revenue guidance has been raised to between $2 billion and $2.05 billion. Axon's adjusted EBITDA reached $123 million, with a margin of 24.5% for the quarter.


Despite these positive developments, executives expressed cautiousness regarding potential economic downturns. However, they also highlighted the fastest growth in their Cloud and Services segment at 47% year-over-year, and an increase in Annual Recurring Revenue (ARR) to $850 million, a 44% increase year-over-year.


Axon's upcoming acquisition of Dedrone is expected to strengthen their position in the drone market. The company remains optimistic about its international prospects, pipeline, and future opportunities, particularly in Europe and the growing acceptance of cloud technology and AI services.


InvestingPro Insights


Adding to Baird's optimistic assessment, InvestingPro data underscores Axon Enterprise's robust financial health and market potential. Notably, Axon's market capitalization stands at a substantial $27.54 billion, reflecting the market's confidence in the company.


The company's impressive revenue growth of over 32% in the last twelve months as of Q2 2024 further validates the potential that Baird sees in Axon's growth opportunities. The gross profit margin of nearly 60% during the same period indicates a strong ability to translate sales into profitability.


An InvestingPro Tip that aligns with the article's positive tone is the expectation of net income growth this year, which could be a significant factor in driving the stock price upward. Moreover, analysts have revised their earnings upwards for the upcoming period, indicating a consensus that Axon's financial performance may exceed previous expectations. These insights, along with 19 additional InvestingPro Tips available at https://www.investing.com/pro/AXON, provide a comprehensive view of why Axon Enterprise is seen as a favorable investment by market experts.


With a forward-looking P/E ratio of 94.38 and a PEG ratio that suggests the stock may be undervalued relative to its earnings growth (0.52), investors may find Axon's valuation compelling. The InvestingPro Fair Value estimate of $254.44, contrasted with Baird's price target of $400, offers a range for investors to consider when evaluating the stock's potential.


As Axon Enterprise continues to integrate advanced technologies and expand its market reach, these financial metrics and analyst insights may serve as valuable indicators for investors monitoring the company's trajectory.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.